Cited by 186Liver physiology and pathologyOrgan Transplantation Techniques and OutcomesDrug Transport and Resistance Mechanisms

Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis

Open access
De Vree, J.Marleen L., Ottenhoff, Roel, Bosma, Piter J., Smith, Alexander J., Aten, Jan, Oude Elferink, Ronald P.J.·2000·Gastroenterology

Abstract

Background & aims Patients with progressive familial intrahepatic cholestasis (PFIC) type 3 have a mutation in the MDR3 gene, encoding the hepatocanalicular phospholipid translocator. In general, liver failure develops within the first decade of life in these patients. Previous studies have shown that in the mdr2-knockout mouse, the animal model for this disease, the absence of phospholipids in bile causes chronic bile salt-induced damage to hepatocytes. We aimed to test the efficacy of hepatocyte transplantation and liver repopulation in this disease model.Methods Transgenic MDR3-expressing hepatocytes as well as normal mdr2(+/+) hepatocytes were transplanted in mdr2(-/-) mice, and liver repopulation was assessed by immunohistochemistry and measurement of biliary lipid secretion.Results Transplanted hepatocytes partially repopulated the liver, restored phospholipid secretion, and diminished liver pathology. Repopulation was stronger when hepatocellular damage was enhanced by a bile salt-supplemented diet. After 1 year, however, these animals developed multiple hepatic tumors, and biliary phospholipid secretion decreased. In transplanted animals receiving a control diet, repopulation was slower but eventually remained stable at 21%, while liver pathology was completely abrogated and tumor formation was prevented.Conclusions These results suggest that moderate liver pathology is a safe condition for the induction of effective hepatocyte repopulation and that this therapy is potentially applicable to patients with PFIC type 3.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1053/gast.2000.20222

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several disorders in which selection has been shown include Fanconi's anemia, Wilson's disease, many bile-acid transporter defects, and junctional epidermolysis bullosa.

    “While this situation is an exception, there are several disorders in which selection has been shown, including Fanconi’s anemia,41 the copper storage disorder Wilson’s disease,42 many bile-acid transporter defects,43 and junctional epidermolysis bullosa44 to name a few.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Anderson WF. Human gene therapy. Nature 1998;392:25-30.

Cited by

Sorted by citations

Authors
De Vree, J. M. L., Ottenhoff, R., Bosma, P. J., Smith, A. J., Aten, J., & Oude Elferink, R. P. J.
Affiliations
Amsterdam UMC Location University of Amsterdam (NL)
Venue
Gastroenterology
Publisher
Elsevier BV
Published
2000-12
Volume
119
Issue
6
Pages
1720-1730
ISSN
0016-5085 (ISSN-L)
OpenAlex
W2115772492
Cited by
186
References
26
Citations by year
2026: 2 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 4 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 11 · 2013: 4 · 2012: 11
Type
journal article
Language
en
Open access
Locations
  • Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
progressive familial intrahepatic cholestasis type 3, hepatocyte transplantation, liver repopulation, biliary phospholipid secretion, liver tumors, liver failure, cholestatic liver disease
MeSH terms
Animals, Cholestasis, Diet, Liver, Liver Neoplasms, Male, Mice, Transgenic, Phospholipids, Mice, Knockout, ATP Binding Cassette Transporter, Subfamily B, ATP-Binding Cassette Transporters, Cholates, Hepatocytes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review